Phenylalanine and Its Impact on Cognition

NCT03788343 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Phenylketonuria

Interventions

DIETARY_SUPPLEMENT: Phenylalanine
DRUG: Placebo

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]